In collaboration with the Foundation for Innovative New Diagnostics and the Hong Kong Supranational Reference Laboratory, PATH assists the Chinese National Tuberculosis Reference Laboratory with determining the operational feasibility, cost-effectiveness, and impact of new tuberculosis diagnostics in order to help the Chinese Ministry of Health decide whether to introduce and scale up these technologies. This fact sheet is presented in English on one side and simplified Chinese on the other.

Corporate author(s): PATH

Publication date: March 2012

Region: Asia

See also: Emerging and epidemic diseases > Tuberculosis

For more information…

Contact: PATH Publications
Email: publications@path.org
Mailing address: PATH, PO Box 900922, Seattle, WA 98109 USA